Sharon Tetlow

Insider Reports History

Entity
Individual
Location
C/O Catalyst Biosciences, Inc., 611 Gateway Blvd., Suite 710, South San Francisco, CA
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sharon Tetlow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. Director Share Option (right to buy) 37.5K Jun 25, 2024 Direct
CATALYST BIOSCIENCES, INC. Director Stock Option (Right to Buy) 14K Jun 9, 2021 Direct
DICE Therapeutics, Inc. Director Common Stock 0 $46.50 Aug 9, 2023 Direct
DICE Therapeutics, Inc. Director Stock Option (right to buy) 0 Aug 9, 2023 Direct

Insider Reports Filed by Sharon Tetlow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GPCR Structure Therapeutics Inc. Jun 25, 2024 1 $0 4 Jun 27, 2024 Director
DICE DICE Therapeutics, Inc. Aug 9, 2023 5 $0 4 Aug 9, 2023 Director
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Director
DICE DICE Therapeutics, Inc. Jun 7, 2022 1 $0 4 Jun 8, 2022 Director
DICE DICE Therapeutics, Inc. Sep 14, 2021 4 $0 4 Sep 16, 2021 Director
DICE DICE Therapeutics, Inc. Sep 14, 2021 0 $0 3 Sep 14, 2021 Director
CBIO CATALYST BIOSCIENCES, INC. Jun 9, 2021 1 $0 4 Jul 2, 2021 Director